Wayspring, an organization dedicated to advancing care for substance use disorder (SUD), and Aetna Better Health® of Illinois ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

A commission of top United Nations human rights watchdogs sent a series of blistering letters to the heads of five U.S. universities raising sharp concerns over the treatment of pro-Palestine students ...

The Trump administration has significantly cut funding for the Substance Abuse and Mental Health Administration (SAMHSA). Disability Rights Wisconsin, a watchdog group that investigates abuse and ...

The Trump administration’s plan to revamp the entire Health and Human Services Department, which Congress has rejected, has nevertheless led to the gutting of a 33-year-old agency that had been ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

More than 4,000 federal workers have received "reduction in force" notices since the federal government shutdown began. Among the agencies hit is the Substance Abuse and Mental Health Services ...

Hundreds of federal employees working on mental health services, disease outbreaks, and disaster preparedness were among those hit by the Trump administration's mass firings over the weekend, current ...

SAMHSA is best known for the rollout of the 988 suicide prevention hotline. Dozens of employees at the Substance Abuse and Mental Health Services Administration were laid off in the wave of government ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.